Which imaging modality is preferred to exclude sarcoidosis as the cause of an elevated prolactin level?

MRI with Gadolinium Enhancement is the Imaging Modality of Choice

For patients with elevated prolactin where neurosarcoidosis is suspected, gadolinium-enhanced MRI of the brain with focus on the sellar region is the preferred imaging modality to rule out sarcoidosis. This recommendation is based on the 2020 American Thoracic Society guidelines which specifically identify gadolinium enhancement on MRI (CNS) as a "highly probable" imaging finding for sarcoidosis 1.

Clinical Context and Reasoning

When evaluating prolactin elevation, neurosarcoidosis involving the hypothalamic-pituitary axis must be considered in the differential diagnosis. Sarcoidosis can infiltrate the pituitary stalk, hypothalamus, and surrounding structures, leading to:

• Hyperprolactinemia (due to stalk effect or direct infiltration)
• Hypogonadotropic hypogonadism
• Diabetes insipidus
• Other pituitary hormone deficiencies 2

The clinical presentation typically includes neurological symptoms (headaches, vision problems) alongside endocrine abnormalities 3.

Why MRI with Gadolinium?

According to the ATS guidelines, gadolinium enhancement on MRI for CNS involvement is classified as "highly probable" evidence for sarcoidosis 1. The characteristic MRI findings in neurosarcoidosis include:

• Diffuse leptomeningeal enhancement
• Pituitary stalk thickening and enhancement
• Hypothalamic involvement
• Optic chiasm involvement 2

Contrast-enhanced MRI is specifically identified as the modality of choice for investigating suspected neurosarcoidosis 3. The versatility of MR sequences and the diagnostic information obtained from MRI examination is superior to other modalities for CNS sarcoidosis.

Diagnostic Algorithm

1. Confirm hyperprolactinemia with repeat measurement (avoid premature imaging) 4, 5

2. Exclude medication-induced causes - particularly antipsychotics, metoclopramide, and other dopamine antagonists 6

3. Assess for systemic sarcoidosis features:

   • Chest imaging (CXR or CT) for bilateral hilar adenopathy
   • Look for extrathoracic manifestations (uveitis, skin lesions, parotid enlargement)
   • Check ACE levels, calcium metabolism 1

4. If neurosarcoidosis suspected (neurological symptoms + hyperprolactinemia + systemic features):

   • Order gadolinium-enhanced MRI of brain with focus on sellar region
   • Look for characteristic leptomeningeal enhancement and hypothalamic-pituitary involvement

Important Caveats

Do not order MRI prematurely. Over half of MRIs ordered for mild hyperprolactinemia are done without proper confirmation by repeat prolactin measurement, leading to incidental findings of uncertain significance 4. The Endocrine Society guidelines recommend waiting 3 days after medication discontinuation before remeasuring prolactin 6.

Correlation with systemic disease is essential. Neurosarcoidosis rarely occurs in isolation - approximately 90% of sarcoidosis cases involve lungs and mediastinal lymph nodes 7. Therefore, chest imaging (CT preferred over CXR for accuracy) should be part of the workup 7.

PET/CT has a role but is secondary. While 18F-FDG PET/CT can be effective in diagnosing and monitoring systemic sarcoidosis with pituitary involvement 8, and parotid uptake on PET is listed as "highly probable" for sarcoidosis 1, MRI with gadolinium remains the primary modality for CNS evaluation per ATS guidelines.

Complementary Imaging

Once neurosarcoidosis is suspected on MRI:

• Chest CT to evaluate for thoracic involvement (bilateral hilar adenopathy, perilymphatic nodules) 1, 7
• Consider whole-body PET/CT for systemic disease assessment and monitoring 8

The diagnosis ultimately requires histopathological confirmation showing non-caseating granulomas with exclusion of infectious causes, but gadolinium-enhanced MRI provides the critical imaging evidence to support CNS involvement 3, 2.